AUC vs Trough Dosing of Tobramycin in Cystic Fibrosis

Randomised, open-label trial of tobramycin in cystic fibrosis (CF), sponsored by Leeds Teaching Hospitals NHS Trust. Primary endpoints: Area Under the Curve of tobramycin at 28 days and Area Under the Curve of Amikacin or Colomycin at 28 days. Status: unknown.